Biocon Biologics refinances $ 1.1 bn long-term debt through USD bonds and new syndicated facility
The Bonds are expected to be rated BB by both S&P and Fitch and will be listed on the Singapore Stock Exchange
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
HSBC
HSBC acquisition of SVB UK may result in for new opportunities for biopharma: GlobalData
According to GlobalData’s Pharma Intelligence Center Deals Database, SVB Financial Group and its subsidiaries were involved in…